Clinical trials
Obesity trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 9 |
| Recruiting | 8 |
| Terminated | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Chile | 6 |
| Pontificia Universidad Catolica de Chile | 5 |
| Amgen | 2 |
| GT Metabolic Solutions, Inc. | 2 |
| Morphic Medical Inc. | 2 |
| Universidad Autónoma de Chile | 2 |
| Universidad Santo Tomas | 2 |
| Alnylam Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boston Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 47 |
| Overweight | 10 |
| Diabetes Mellitus, Type 2 | 8 |
| Metabolic Syndrome | 5 |
| Diabetes Mellitus | 4 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
| Weight Loss | 3 |
| Periodontitis | 2 |
| Pregnancy in Obesity | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.